HBK Investments’s AstraZeneca AZN Stock Holding History

HBK Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-104,911	Closed	-$8.48M	–	637
2019 Q1	$8.48M	Buy	+104,911	New	+$8.27M	0.09%	195
2018 Q3	–	Sell	-59,550	Closed	-$4.18M	–	1169
2018 Q2	$4.18M	Buy	+59,550	New	+$4.28M	0.03%	311
2018 Q1	–	Sell	-11,700	Closed	-$812K	–	969
2017 Q4	$812K	Buy	+11,700	New	+$789K	0.01%	652
2015 Q2	–	Sell	-40,506	Closed	-$2.77M	–	936
2015 Q1	$2.77M	Sell	40,506 -4,345	-10%	-$302K	0.03%	338
2014 Q4	$3.16M	Sell	44,851 -26,349	-37%	-$1.89M	0.04%	295
2014 Q3	$5.09M	Sell	71,200 -28,200	-28%	-$2.06M	0.08%	205
2014 Q2	$7.39M	Buy	+99,400	New	+$7.19M	0.15%	124
2013 Q3	–	Sell	-28,500	Closed	-$1.35M	–	864
2013 Q2	$1.35M	Buy	+28,500	New	+$1.45M	0.02%	338

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

HBK Investments's AZN Position: Q2 2019 in Review

HBK Investments sold out of AstraZeneca (AZN) in Q2 2019, closing a stake of 104,911 shares — an estimated $8.48M sold.

HBK Investments first reported a position in AZN in Q2 2013 and held it in 8 quarters. The position peaked at $8.48M in Q1 2019. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

HBK Investments reported no remaining AstraZeneca position as of Q2 2019 after selling out during the quarter.
HBK Investments sold 104,911 AstraZeneca shares in Q2 2019, an estimated $8.48M.
HBK Investments first reported a position in AstraZeneca in Q2 2013 and held it in 8 quarters.
HBK Investments's AstraZeneca position peaked at $8.48M in Q1 2019.
546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.